872
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Potential significance of changes in serum levels of IL-17, TNF-α and DKK-1 in the progression of the rheumatoid arthritis

ORCID Icon, , , , , , , , , , , , & show all
Article: 2276068 | Received 26 Mar 2023, Accepted 21 Oct 2023, Published online: 01 Nov 2023

References

  • Hulsmans H-M, Jacobs J-W, van der Heijde D-M, et al. The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum. 2000;43(9):1–7.
  • Firestein G-S, McInnes I-B. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183–196.
  • Maruotti N, Corrado A, Neve A, et al. Systemic effects of wnt signaling. J Cell Physiol. 2013;228(7):1428–1432.
  • Miao C-G, Yang Y-Y, He X, et al. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal. 2013;25(10):2069–2078.
  • Singh A, Gupta M-K, Mishra S-P. Study of correlation of level of expression of wnt signaling pathway inhibitors sclerostin and dickkopf-1 with disease activity and severity in rheumatoid arthritis patients. Drug Discov Ther. 2019;13(1):22–27.
  • Seror R, Boudaoud S, Pavy S, et al. Increased dickkopf-1 in recent-onset rheumatoid arthritis is a new biomarker of structural severity. Data from the ESPOIR cohort. Sci Rep. 2016;6:18421.
  • Munno OD, Ferro F. The effect of biologic agents on bone homeostasis in chronic inflammatory rheumatic diseases. Clin Exp Rheumatol. 2019;37(3):502–507.
  • Cici D, Corrado A, Rotondo C, et al. Wnt signaling and biological therapy in rheumatoid arthritis and spondyloarthritis. Int J Mol Sci. 2019;20(22):5552.
  • Xie W, Zhou L, Li S, et al. Wnt/β-catenin signaling plays a key role in the development of spondyloarthritis. Ann NY Acad Sci. 2016;1364(1):25–31.
  • Ellwanger K, Saito H, Clement-Lacroix P, et al. Targeted disruption of the wnt regulator Kremen induces limb defects and high bone density. Mol Cell Biol. 2008;28(15):4875–4882.
  • Fischer J-A, Hueber A-J, Wilson S, et al. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody. Arthritis Rheumatol. 2015;67(1):51–62.
  • Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med. 2007;13(2):156–163.
  • Fraenkel L, Bathon J-M, England B-R, et al. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2021;73(7):1108–1123.
  • van Riel P-L, Renskers L. The disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol. 2016;34(5 Suppl 101):S40–S44.
  • Najm A, Masson F-M, Preuss P, et al. MicroRNA-17-5p reduces inflammation and bone erosions in mice with Collagen-Induced arthritis and directly targets the JAK/STAT pathway in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol. 2020;72(12):2030–2039.
  • Hu T, Liu Y, Tan L, et al. Value of serum collagen triple helix repeat containing-1(CTHRC1) and 14-3-3eta protein compared to anti-CCP antibodies and anti-MCV antibodies in the diagnosis of rheumatoid arthritis. Br J Biomed Sci. 2021;78(2):67–71.
  • Volkov M, Karin-Anna S, Diane W. Autoantibodies and B cells: the ABC of rheumatoid arthritis pathophysiology. Immunol Rev. 2020;294(1):148–163.
  • Tan L, Ouyang T, Li X, et al. Serum sirtuin-1 a potential marker in the diagnosis of rheumatoid arthritis. Autoimmunity. 2023;56(1):2181234.
  • Wei S-T, Sun Y-H, Zong S-H, et al. Serum levels of IL-6 and TNF-alpha may correlate with activity and severity of rheumatoid arthritis. Med Sci Monit. 2015;21:4030–4038.
  • Jovanovic D-V, Martel-Pelletier J, Di Battista J-A, et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheumatism. 2000;43(5):1134–1144.
  • Lee B, Jo Y, Kim G, et al. Specific inhibition of soluble gammac receptor attenuates Collagen-Induced arthritis by modulating the inflammatory T cell responses. Front Immunol. 2019;10:209.
  • Lee S-J, Lee A, Hwang S-R, et al. TNF-alpha gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis. Mol Ther. 2014;22(2):397–408.
  • Moelants E-A, Mortier A, Van Damme J, et al. Regulation of TNF-α with a focus on rheumatoid arthritis. Immunol Cell Biol. 2013;91(6):393–401.
  • Wang S-Y, Liu Y-Y, Ye H, et al. Circulating dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. J Rheumatol. 2011;38(5):821–827.
  • Fassio A, Adami G, Gatti D, et al. Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators. Int Immunopharmacol. 2019;67:487–489.
  • Kuwabara T, Ishikawa F, Kondo M, et al. The role of IL-17 and related cytokines in inflammatory autoimmune diseases. Mediators Inflamm. 2017;2017:3908061.
  • Ruaro B, Casabella A, Paolino S, et al. Dickkopf-1 (dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the trabecular bone score (TBS). Clin Rheumatol. 2018;37(11):3057–3062.
  • Zhang X, Yuan Y, Pan Z, et al. Elevated circulating IL-17 level is associated with inflammatory arthritis and disease activity: a meta-analysis. Clin Chim Acta. 2019;496:76–83.